Heart Failure-Related Cardiogenic Shock: A Distinct Haemometabolic Syndrome
Heart, Lung and Circulation · 2026-11
DOI: 10.1016/j.hlc.2026.06.016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Heart, Lung and Circulation, 2026-11. Verfasst von Joanne Eng-Frost und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Flinders Medical Centre, Bedford Park, SA, Australia; College of Medicine and Public Health, Flinders University, Bedford P…. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Cardiogenic shock (CS) is increasingly recognised as a heterogeneous syndrome, with heart failure-related cardiogenic shock (HF-CS) now representing the predominant aetiology. However, contemporary diagnostic and therapeutic frameworks remain largely extrapolated from acute myocardial infarction-related cardiogenic shock (AMI-CS), despite fundamental differences in pathophysiology and clinical trajectories. In HF-CS, pathophysiology is better conceptualised as a haemometabolic construct in which congestion, impaired forward flow, and systemic metabolic dysfunction interact to drive progressive multiorgan failure. These processes are often poorly captured by conventional blood pressure (BP)–based definitions of CS, particularly in heart failure, where patients may have persistently low yet compensated baseline BP. Although the Society of Cardiovascular and Angiographic Interventions shock classification provides a useful severity-based framework, emerging evidence supports a more integrated diagnostic approach that incorporates biomarkers such as lactate, mixed venous oxygen saturation, and invasive haemodynamic profiling. Together, these measures may improve risk stratification and better guide the timing and selection of escalation strategies. In parallel, multidisciplinary shock team models may improve outcomes in HF-CS, particularly when implemented early, before irreversible end-organ dysfunction develops. Future advances in HF-CS will require a shift away from BP-centric definitions derived from AMI-CS towards a comprehensive haemometabolic framework integrating congestion, perfusion, and haemometabolic status. Prospective HF-CS specific trials evaluating early, phenotype-guided care within structured, protocol-driven systems are essential to improving outcomes in this growing and clinically complex population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Flinders Medical Centre, Bedford Park, SA, Australia; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia. Electronic address: joanne.eng-frost@sa.gov.au.
- Department of Cardiology, Flinders Medical Centre, Bedford Park, SA, Australia; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.
- Department of Cardiology, Flinders Medical Centre, Bedford Park, SA, Australia; Department of Cardiology, The Queen Elizabeth Hospital, Woodville South, SA, Australia; Department of Cardiology, Royal Adelaide Hospital,…
- Department of Cardiology, Flinders Medical Centre, Bedford Park, SA, Australia; Department of Cardiology, Royal Adelaide Hospital, Adelaide, SA, Australia.
- Department of Cardiology, Flinders Medical Centre, Bedford Park, SA, Australia.
Zitieren
APA
Eng-Frost, J., Burdeniuk, C., Chan, A., Parvar, S., Gunton, J., & De Pasquale, C. G. (2026). Heart Failure-Related Cardiogenic Shock: A Distinct Haemometabolic Syndrome. Heart, Lung and Circulation. https://doi.org/10.1016/j.hlc.2026.06.016
Vancouver
Eng-Frost J, Burdeniuk C, Chan A, Parvar S, Gunton J, De Pasquale CG. Heart Failure-Related Cardiogenic Shock: A Distinct Haemometabolic Syndrome. Heart, Lung and Circulation. 2026. doi:10.1016/j.hlc.2026.06.016
BibTeX
@article{EngFrost2026,
author = {Eng-Frost, Joanne and Burdeniuk, Christine and Chan, Alicia and Parvar, Saman and Gunton, James and De Pasquale, Carmine G},
title = {Heart Failure-Related Cardiogenic Shock: A Distinct Haemometabolic Syndrome},
journal = {Heart, Lung and Circulation},
year = {2026},
doi = {10.1016/j.hlc.2026.06.016}
}
EUVIMED